NORWALK, Conn.--(BUSINESS WIRE)--One month after Congressional elections usher in a new Congress with an intensified focus on the Food and Drug Administration (FDA), Acting FDA Commissioner Andrew von Eschenbach, MD will address issues of critical importance to the pharmaceuticals industry at Windhover Information’s and The RPM Report’s FDA/CMS Summit.
